Mahamaya Lifesciences Ltd
ncorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management.[1]
- Market Cap ₹ 416 Cr.
- Current Price ₹ 178
- High / Low ₹ 205 / 111
- Stock P/E 25.2
- Book Value ₹ 52.1
- Dividend Yield 0.00 %
- ROCE 20.0 %
- ROE 19.3 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE SME IPO
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 90 | 137 | 161 | 264 | 329 | |
| 84 | 128 | 148 | 241 | 296 | |
| Operating Profit | 6 | 9 | 13 | 23 | 34 |
| OPM % | 7% | 6% | 8% | 9% | 10% |
| 0 | 0 | 1 | 3 | 1 | |
| Interest | 2 | 3 | 6 | 7 | 8 |
| Depreciation | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 4 | 5 | 7 | 17 | 24 |
| Tax % | 27% | 26% | 27% | 25% | 31% |
| 3 | 4 | 5 | 13 | 17 | |
| EPS in Rs | 21.78 | 30.03 | 41.80 | 7.28 | 7.06 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 34% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 64% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 24% |
| Last Year: | 19% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 18 | 23 |
| Reserves | 14 | 18 | 23 | 32 | 99 |
| 19 | 24 | 55 | 58 | 91 | |
| 21 | 34 | 33 | 81 | 98 | |
| Total Liabilities | 56 | 78 | 112 | 188 | 310 |
| 20 | 21 | 21 | 27 | 38 | |
| CWIP | 2 | 2 | 3 | 4 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 34 | 54 | 88 | 157 | 267 | |
| Total Assets | 56 | 78 | 112 | 188 | 310 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 2 | 1 | -23 | 1 | -30 | |
| -3 | -3 | -2 | -8 | -16 | |
| 1 | 2 | 24 | 9 | 81 | |
| Net Cash Flow | 0 | 1 | -0 | 1 | 35 |
| Free Cash Flow | -1 | -2 | -25 | -8 | -46 |
| CFO/OP | 56% | 24% | -162% | 12% | -75% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 37 | 25 | 64 | 67 | 78 |
| Inventory Days | 93 | 109 | 137 | 167 | |
| Days Payable | 83 | 87 | 61 | 92 | |
| Cash Conversion Cycle | 47 | 48 | 140 | 142 | 78 |
| Working Capital Days | 8 | 9 | 14 | 29 | 49 |
| ROCE % | 20% | 21% | 26% | 20% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Advertisement of Completion of Dispatch of the Notice of 24th Annual General Meeting
-
Reg. 34 (1) Annual Report.
- Annual Report for FY 2025-26 submitted and shared with members.
-
Notice Of 24Th Annual General Meeting Of The Company
- 24th AGM on Sept. 29, 2026; proposes MD redesignation, new Managing Director, director reappointments, and cost auditor ratification.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Advertisement regarding pre-dispatch intimation of 24th AGM of the Company
-
Announcement under Regulation 30 (LODR)-Change in Directorate
- Board approved AGM on 29 Sep 2026; MD relinquishment, CFO resignation, and key appointments effective Nov 2026.
Business Profile[1]
The company manufactures pesticide formulations and supplies bulk products to Indian agrochemical companies and multinational corporations (MNCs). It imports scientifically researched molecules, secures registrations with the Central Insecticides Board, and develops these molecules into technical-grade and value-added formulations, which are marketed to domestic manufacturers and global MNCs.